I would like to point out that we are receiving growing support from stakeholders for the potential to advance a novel ...

Experts in the fields of brain health, Alzheimer’s disease, caregiving and legal and long-term planning will speak to ...

There exists no ‘amyloid cabal’” in Alzheimer’s research, neurologist Dennis Selkoe writes in response to Charles Piller’s “Doctored.” ...

Using a new animal model of Alzheimer’s disease, the study highlights a potential breakthrough in treatment strategies.

Imagine you have just been diagnosed with mild cognitive decline due to Alzheimer’s disease. Your doctor might suggest taking ...

In the past two years, the Food and Drug Administration has approved two novel Alzheimer's therapies, based on data from clinical trials showing that both drugs slowed the progression of the disease.

Doctors and aging experts say early intervention is key. When dementia is diagnosed early on, there are more treatment and ...

In the past two years, the Food and Drug Administration has approved two novel Alzheimer's therapies, based on data from ...

BOSTON, MA / ACCESS Newswire / February 13, 2025 / Medisafe, the leading digital health and patient engagement platform, is proud to announce the launch of PATHWAYS, a new, complimentary tool designed ...

Today, as part of a national initiative funded by The John A. Hartford Foundation (JAHF), the national, independent nonprofit FAIR Health launched a new shared decision-making tool for Alzheimer's ...

WashU Medicine-led trial evaluating investigational drug from Eli Lilly and Company aims to stop disease before symptoms arise Researchers at Washington University School of Medicine in St. Louis have ...